The global oncolytic virus therapies market is expanding rapidly, driven by advancements in immunotherapy and rising cancer prevalence. Key trends include increased R&D investments, strategic collaborations, and a focus on combination therapies. North America leads due to robust healthcare infrastructure, while Asia-Pacific shows growth potential with rising clinical trials and approvals. More Info: https://www.imarcgroup.com/oncolytic-virus-therapies-market